United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - fosamprenavir calcium - tablet - 700mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - fosamprenavir calcium - oral suspension - 50mg/1ml

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

European Union - English - EMA (European Medicines Agency)

viiv healthcare bv - fosamprenavir calcium - hiv infections - antivirals for systemic use - telzir in combination with low-dose ritonavir is indicated for the treatment of human-immunodeficiency-virus-type-1-infected adults, adolescents and children of six years and above in combination with other antiretroviral medicinal products. in moderately antiretroviral-experienced adults, telzir in combination with low-dose ritonavir has not been shown to be as effective as lopinavir / ritonavir. no comparative studies have been undertaken in children or adolescents. in heavily pretreated patients, the use of telzir in combination with low-dose ritonavir has not been sufficiently studied. in protease-inhibitor-experienced patients, the choice of telzir should be based on individual viral resistance testing and treatment history.,

Canada - English - Health Canada

viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - tablet - 700mg - fosamprenavir (fosamprenavir calcium) 700mg - hiv protease inhibitors

Canada - English - Health Canada

viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - suspension - 50mg - fosamprenavir (fosamprenavir calcium) 50mg - hiv protease inhibitors